The role of the mitochondrial permeability transition pore in heart disease

Biochimica et Biophysica Acta - Bioenergetics

Volumn 1787, Issue 11, 2009, Pages 1402-1415

  Halestrap, Andrew P ^a   Pasdois, Philippe ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Adenine nucleotide translocase; Calcium; Cyclophilin D; Cyclosporin A; Heart; Ischaemia; Mitochondrial permeability transition pore; Mitochondrial phosphate carrier; Reactive oxygen specie; Reperfusion

Indexed keywords

ADENINE NUCLEOTIDE; ADENINE NUCLEOTIDE TRANSLOCASE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; CYCLOPHILIN D; CYCLOSPORIN A; CYCLOSPORIN A [3 N METHYL DEXTRO ALANINE 4 N ETHYLVALINE]; PHOSPHATE TRANSPORTER; PROPOFOL; PYRUVIC ACID; REACTIVE OXYGEN METABOLITE; SODIUM PROTON EXCHANGE PROTEIN; TRIMETAZIDINE; UROCORTIN; VOLTAGE DEPENDENT ANION CHANNEL;

APOPTOSIS; CALCIUM SIGNALING; CALCIUM TRANSPORT; CHANNEL GATING; CONGESTIVE HEART FAILURE; CORONARY ARTERY THROMBOSIS; ENERGY METABOLISM; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; ISCHEMIC PRECONDITIONING; MITOCHONDRIAL PERMEABILITY; MITOCHONDRIAL RESPIRATION; MITOCHONDRION SWELLING; NONHUMAN; OXIDATIVE STRESS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW;

ANIMALS; CARDIOMEGALY; CYCLOPHILINS; HEART DISEASES; HEART FAILURE; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MITOCHONDRIAL ADP, ATP TRANSLOCASES; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCARDIAL REPERFUSION INJURY;

ANIMALIA;

EID: 68649090703     PISSN: 00052728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbabio.2008.12.017     Document Type: Review

References (226)

1. Crompton M. The regulation of mitochondrial calcium transport in hear. Curr. Top. Membr. Transp. 25 (1985) 231-276
2. 2+ transport mechanisms. Biochim. Biophys. Acta 1787 (2009) 1291-1308
3. Bell C.J., Bright N.A., Rutter G.A., and Griffiths E.J. ATP regulation in adult rat cardiomyocytes: time-resolved decoding of rapid mitochondrial calcium spiking imaged with targeted photoproteins. J. Biol. Chem. 281 (2006) 28058-28067
4. Griffiths E.J., and Rutter G.A. Mitochondrial calcium as a key regulator of mitochondrial ATP production in mammalian cells. Biochim. Biophys. Acta 1787 (2009) 1324-1333
5. McCormack J.G., Halestrap A.P., and Denton R.M. The role of calcium ions in the regulation of mammalian intramitochondrial metabolism. Physiol. Rev. 70 (1990) 391-425
6. 2+ transport. J. Bioenerg. Biomembr. 26 (1994) 495-508
7. Denton R.M. Regulation of mitochondrial dehydrogenases by calcium ions. Biochim. Biophys. Acta 1787 (2009) 1309-1316
8. 2+ signaling in the coordination of mitochondrial ATP production with cardiac work. Biochim. Biophys. Acta 1787 (2009) 1334-1341
9. Harris D.A. Regulation of the mitochondrial ATP synthase in rat heart. Biochem. Soc. Trans. 21 (1993) 778-781
10. Halestrap A.P. The regulation of the matrix volume of mammalian mitochondria in vivo and in vitro, and its role in the control of mitochondrial metabolism. Biochim. Biophys. Acta 973 (1989) 355-382
11. Balaban R.S. Cardiac energy metabolism homeostasis: role of cytosolic calcium. J. Mol. Cell. Cardiol. 34 (2002) 1259-1271
12. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem. J. 341 (1999) 233-249
13. Halestrap A.P., Clarke S.J., and Javadov S.A. Mitochondrial permeability transition pore opening during myocardial reperfusion - a target for cardioprotection. Cardiovasc. Res. 61 (2004) 372-385
14. Halestrap A.P. Calcium, mitochondria and reperfusion injury: a pore way to die. Biochem. Soc. Trans. 34 (2006) 232-237
15. DiLisa F., and Bernardi P. Mitochondria and ischemia-reperfusion injury of the heart: fixing a hole. Cardiovasc. Res. 70 (2006) 191-199
16. Halestrap A.P., Kerr P.M., Javadov S., and Woodfield K.Y. Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart. Biochim. Biophys. Acta 1366 (1998) 79-94
17. Halestrap A.P. The nature of the stimulation of the respiratory chain of rat liver mitochondria by glucagon pretreatment of animals. Biochem. J. 204 (1982) 37-47
18. Petronilli V., Nicolli A., Costantini P., Colonna R., and Bernardi P. Regulation of the permeability transition pore, a voltage-dependent mitochondrial channel inhibited by cyclosporin A. Biochim. Biophys. Acta 1187 (1994) 255-259
19. Crompton M., Barksby E., Johnson N., and Capano M. Mitochondrial intermembrane junctional complexes and their involvement in cell death. Biochimie 84 (2002) 143-152
20. Martinou J.C., and Green D.R. Breaking the mitochondrial barrier. Nat. Rev. Mol. Cell. Biol. 2 (2001) 63-67
21. Green D.R., and Kroemer G. The pathophysiology of mitochondrial cell death. Science 305 (2004) 626-629
22. Gunter T.E., and Pfeiffer D.R. Mechanisms by which mitochondria transport calcium. Am. J. Physiol. 258 (1990) C755-C786
23. 2+ plus N-ethylmaleimide on mitochondrial function. J. Biol. Chem. 254 (1979) 11485-11494
24. Halestrap A.P., McStay G.P., and Clarke S.J. The permeability transition pore complex: another view. Biochimie 84 (2002) 153-166
25. 2+ trigger site. Arch. Biochem. Biophys. 195 (1979) 460-467
26. 2+-induced membrane transition in mitochondria. I. The protective mechanisms. Arch. Biochem. Biophys. 195 (1979) 453-459
27. 2+-dependent pore activated by oxidative stress in heart mitochondria. Biochem. J. 245 (1987) 915-918
28. Leung A.W., and Halestrap A.P. Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore. Biochim. Biophys. Acta 1777 (2008) 946-952
29. 2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem. J. 255 (1988) 357-360
30. 2+-induced large amplitude swelling of liver and heart mitochondria by cyclosporin A is probably caused by the inhibitor binding to mitochondrial matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. Biochem. J. 268 (1990) 153-160
31. Connern C.P., and Halestrap A.P. Purification and N-terminal sequencing of peptidyl-prolyl cis-trans-isomerase from rat liver mitochondrial matrix reveals the existence of a distinct mitochondrial cyclophilin. Biochem. J. 284 (1992) 381-385
32. 2+ and oxidant stress. Eur. J. Biochem. 238 (1996) 166-172
33. Griffiths E.J., and Halestrap A.P. Further evidence that cyclosporin-A protects mitochondria from calcium overload by inhibiting a matrix peptidyl-prolyl cis-trans isomerase - implications for the immunosuppressive and toxic effects of cyclosporin. Biochem. J. 274 (1991) 611-614
34. Clarke S.J., McStay G.P., and Halestrap A.P. Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A. J. Biol. Chem. 277 (2002) 34793-34799
35. Johnson N., Khan A., Virji S., Ward J.M., and Crompton M. Import and processing of heart mitochondrial cyclophilin D. Eur. J. Biochem. 263 (1999) 353-359
36. Basso E., Fante L., Fowlkes J., Petronilli V., Forte M.A., and Bernardi P. Properties of the permeability transition pore in mitochondria devoid of cyclophilin D. J. Biol. Chem. 280 (2005) 18558-18561
37. Nakagawa T., Shimizu S., Watanabe T., Yamaguchi O., Otsu K., Yamagata H., Inohara H., Kubo T., and Tsujimoto Y. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434 (2005) 652-658
38. Baines C.P., Kaiser R.A., Purcell N.H., Blair N.S., Osinska H., Hambleton M.A., Brunskill E.W., Sayen M.R., Gottlieb R.A., Dorn G.W., Robbins J., and Molkentin J.D. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434 (2005) 658-662
39. Schinzel A.C., Takeuchi O., Huang Z.H., Fisher J.K., Zhou Z.P., Rubens J., Hetz C., Danial N.N., Moskowitz M.A., and Korsmeyer S.J. Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 12005-12010
40. Halestrap A.P., Woodfield K.Y., and Connern C.P. Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase. J. Biol. Chem. 272 (1997) 3346-3354
41. He L.H., and Lemasters J.J. Regulated and unregulated mitochondrial permeability transition pores: a new paradigm of pore structure and function?. FEBS Lett. 512 (2002) 1-7
42. Novgorodov S.A., Gudz T.I., Jung D.W., and Brierley G.P. The non-specific inner membrane pore of liver mitochondria - modulation of cyclosporin sensitivity by ADP at carboxyatractyloside-sensitive and insensitive sites. Biochem. Biophys. Res. Commun. 180 (1991) 33-38
43. Klingenberg M. The ADP and ATP transport in mitochondria and its carrier. Biochim. Biophys. Acta 1778 (2008) 1978-2021
44. Halestrap A.P., and Brenner C. The adenine nucleotide translocase: a central component of the mitochondrial permeability transition pore and key player in cell death. Curr. Med. Chem. 10 (2003) 1507-1525
45. Woodfield K., Ruck A., Brdiczka D., and Halestrap A.P. Direct demonstration of a specific interaction between cyclophilin-D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transition. Biochem. J. 336 (1998) 287-290
46. Crompton M., Virji S., and Ward J.M. Cyclophilin-D binds strongly to complexes of the voltage-dependent anion channel and the adenine nucleotide translocase to form the permeability transition pore. Eur. J. Biochem. 258 (1998) 729-735
47. Connern C.P., and Halestrap A.P. Recruitment of mitochondrial cyclophilin to the mitochondrial inner membrane under conditions of oxidative stress that enhance the opening of a calcium-sensitive non-specific channel. Biochem. J. 302 (1994) 321-324
48. McStay G.P., Clarke S.J., and Halestrap A.P. Role of critical thiol groups on the matrix surface of the adenine nucleotide translocase in the mechanism of the mitochondrial permeability transition pore. Biochem. J. 367 (2002) 541-548
49. 2+. Biochemistry 35 (1996) 8483-8488
50. 2+-dependent channel formed by recombinant ADP/ATP carrier from Neurospora crassa resembles the mitochondrial permeability transition pore. Biochemistry 41 (2002) 11804-11811
51. Kokoszka J.E., Waymire K.G., Levy S.E., Sligh J.E., Cal J.Y., Jones D.P., MacGregor G.R., and Wallace D.C. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 427 (2004) 461-465
52. Halestrap A.P. Dual role for the ADP/ATP translocator?. Nature 430 (2004) U1
53. Leung A.W.C., Varanyuwatana P., and Halestrap A.P. The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition. J. Biol. Chem. 283 (2008) 26312-26323
54. Walter L., Nogueira V., Leverve X., Heitz M.P., Bernardi P., and Fontaine E. Three classes of ubiquinone analogs regulate the mitochondrial permeability transition pore through a common site. J. Biol. Chem. 275 (2000) 29521-29527
55. Basso E., Petronilli V., Forte M.A., and Bernardi P. Phosphate is essential for inhibition of the mitochondrial permeability transition pore by cyclosporin a and by cyclophilin D ablation. J. Biol. Chem. 283 (2008) 26307-26311
56. Alcala S., Klee M., Fernandez J., Fleischer A., and Pimentel-Muinos F.X. A high-throughput screening for mammalian cell death effectors identifies the mitochondrial phosphate carrier as a regulator of cytochrome c release. Oncogene 27 (2008) 44-54
57. Tafani M., Minchenko D.A., Serroni A., and Farber J.L. Induction of the mitochondrial permeability transition mediates the killing of HeLa cells by staurosporine. Cancer. Res. 61 (2001) 2459-2466
58. Crompton M. On the involvement of mitochondrial intermembrane junctional complexes in apoptosis. Curr. Med. Chem. 10 (2003) 1473-1484
59. Bernardi P., Krauskopf A., Basso E., Petronilli V., Blalchy-Dyson E., DiLisa F., and Forte M.A. The mitochondrial permeability transition from in vitro artifact to disease target. FEBS. J. 273 (2006) 2077-2099
60. Fontaine E., Ichas F., and Bernardi P. A ubiquinone-binding site regulates the mitochondrial permeability transition pore. J. Biol. Chem. 273 (1998) 25734-25740
61. Cesura A.M., Pinard E., Schubenel R., Goetschy V., Friedlein A., Langen H., Polcic P., Forte M.A., Bernardi P., and Kemp J.A. The voltage-dependent anion channel is the target for a new class of inhibitors of the mitochondrial permeability transition pore. J. Biol. Chem. 278 (2003) 49812-49818
62. Krauskopf A., Eriksson O., Craigen W.J., Forte M.A., and Bernardi P. Properties of the permeability transition in VDAC1(-/-) mitochondria. Biochim. Biophys. Acta 1757 (2006) 590-595
63. Baines C.P., Kaiser R.A., Sheiko T., Craigen W.J., and Molkentin J.D. Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat. Cell Biol. 9 (2007) 550-555
64. Ko Y.H., Delannoy M., Hullihen J., Chiu W., and Pedersen P.L. Mitochondrial ATP synthasome - cristae-enriched membranes and a multiwell detergent screening assay yield dispersed single complexes containing the ATP synthase and carriers for Pi and ADP/ATP. J. Biol. Chem. 278 (2003) 12305-12309
65. Chen C., Ko Y., Delannoy M., Ludtke S.J., Chiu W., and Pedersen P.L. Mitochondrial ATP synthasome: three-dimensional structure by electron microscopy of the ATP synthase in complex formation with carriers for Pi and ADP/ATP. J. Biol. Chem. 279 (2004) 31761-31768
66. 2+ overloading, trigger pH- and mitochondrial permeability transition-dependent death of adult rat myocytes after ischemia-reperfusion. Am. J. Physiol. 290 (2006) H2024-H2034
67. Juhaszova M., Wang S., Zorov D.B., Bradley Nuss H., Gleichmann M., Mattson M.P., and Sollott S.J. The identity and regulation of the mitochondrial permeability transition pore: where the known meets the unknown. Ann. NY. Acad. Sci. 1123 (2008) 197-212
68. Krämer R. Mitochondrial carrier proteins can reversibly change their transport mode: the cases of the aspartate/glutamate and the phosphate carrier. Exp. Physiol. 83 (1998) 259-265
69. Stappen R., and Krämer R. Functional properties of the reconstituted phosphate carrier from bovine heart mitochondria - evidence for asymmetric orientation and characterization of 3 different transport modes. Biochim. Biophys. Acta 1149 (1993) 40-48
70. Jennings R.B., and Reimer K.A. The cell biology of acute myocardial ischemia. Annu. Rev. Med. 42 (1991) 225-246
71. Appleyard R.F., and Cohn L.H. Myocardial stunning and reperfusion injury in cardiac surgery. J. Card. Surg. 8 (1993) 316-324
72. Suleiman M.S., Halestrap A.P., and Griffiths E.J. Mitochondria: a target for myocardial protection. Pharmacol. Ther. 89 (2001) 29-46
73. Yellon D.M., and Hausenloy D.J. Myocardial reperfusion injury. N. Engl. J. Med. 357 (2007) 1121-1135
74. Fliss H., and Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ. Res. 79 (1996) 949-956
75. Anversa P., Cheng W., Liu Y., Leri A., Redaelli G., and Kajstura J. Apoptosis and myocardial infarction. Basic Res. Cardiol. 93 (1998) 8-12
76. Zweier J.L., and Talukder M.A.H. The role of oxidants and free radicals in reperfusion injury. Cardiovasc. Res. 70 (2006) 181-190
77. Nishino T. The conversion of xanthine dehydrogenase to xanthine oxidase and the role of the enzyme in reperfusion injury. J. Biochem. (Tokyo). 116 (1994) 1-6
78. Pacher P., Nivorozhkin A., and Szabo C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol. Rev. 58 (2006) 87-114
79. Becker L.B. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc. Res. 61 (2004) 461-470
80. Kevin L.G., Novalija E., and Stowe D.F. Reactive oxygen species as mediators of cardiac injury and protection: the relevance to anesthesia practice. Anesth. Analg. 101 (2005) 1275-1287
81. 2 radicals in intact hearts with ischemia and reperfusion. Am. J. Physiol. 284 (2003) H566-H574
82. Murphy M.P. How mitochondria produce reactive oxygen species. Biochem. J. 417 (2009) 1-13
83. Khaliulin I., Schwalb H., Wang P., Houminer E., Grinberg L., Katzeff H., Borman J.B., and Powell S.R. Preconditioning improves postischemic mitochondrial function and diminishes oxidation of mitochondrial proteins. Free Radic. Biol. Med. 37 (2004) 1-9
84. Javadov S.A., Clarke S., Das M., Griffiths E.J., Lim K.H.H., and Halestrap A.P. Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart. J. Physiol. 549 (2003) 513-524
85. Halestrap A.P., Clarke S.J., and Khaliulin I. The role of mitochondria in protection of the heart by preconditioning. Biochim. Biophys. Acta 1767 (2007) 1007-1031
86. Allen S.P., Darleyusmar V.M., Mccormack J.G., and Stone D. Changes in mitochondrial matrix free calcium in perfused rat hearts subjected to hypoxia reoxygenation. J. Mol. Cell. Cardiol. 25 (1993) 949-958
87. Silverman H.S., and Stern M.D. Ionic basis of ischaemic cardiac injury: insights from cellular studies. Cardiovasc. Res. 28 (1994) 581-597
88. 2+], and NADH with dysfunction after global ischemia in intact hearts. Am. J. Physiol. 280 (2001) H280-H293
89. 2+ overload reduces myocardial injury induced by ischemia and reperfusion. Acta Pharmacologica. Sinica. 27 (2006) 911-918
90. Halestrap A.P. Calcium-dependent opening of a non-specific pore in the mitochondrial inner membrane is inhibited at pH values below 7 - implications for the protective effect of low ph against chemical and hypoxic cell damage. Biochem. J. 278 (1991) 715-719
91. Ford D.A. Alterations in myocardial lipid metabolism during myocardial ischemia and reperfusion. Prog. Lipid. Res. 41 (2002) 6-26
92. Chen M., Won D.J., Krajewski S., and Gottlieb R.A. Calpain and mitochondria in ischemia/reperfusion injury. J. Biol. Chem. 277 (2002) 29181-29186
93. Capano M., and Crompton M. Bax translocates to mitochondria of heart cells during simulated ischaemia: involvement of AMP-activated and p38 mitogen-activated protein kinases. Biochem. J. 395 (2006) 57-64
94. Bolli R., and Marban E. Molecular and cellular mechanisms of myocardial stunning. Physiol. Rev. 79 (1999) 609-634
95. Piper H.M., Meuter K., and Schafer C. Cellular mechanisms of ischemia-reperfusion injury. Ann. Thorac. Surg. 75 (2003) S644-S648
96. Skyschally A., Schulz R., and Heusch G. Pathophysiology of myocardial infarction: protection by ischemic pre- and postconditioning. Herz 33 (2008) 88-100
97. Miyata H., Lakatta E.G., Stern M.D., and Silverman H.S. Relation of mitochondrial and cytosolic free calcium to cardiac myocyte recovery after exposure to anoxia. Circ. Res. 71 (1992) 605-613
98. Brand M.D., Affourtit C., Esteves T.C., Green K., Lambert A.J., Miwa S., Pakay J.L., and Parker N. Mitochondrial superoxide: production, biological effects, and activation of uncoupling proteins. Free Radic. Biol. Med. 37 (2004) 755-767
99. Orrenius S., Gogvadze V., and Zhivotovsky B. Mitochondrial oxidative stress: implications for cell death. Annu. Rev. Pharmacol. Toxicol. 47 (2007) 143-183
100. Solaini G., and Harris D.A. Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion. Biochem. J. 390 (2005) 377-394
101. Eaton P., Byers H.L., Leeds N., Ward M.A., and Shattock M.J. Detection, quantitation, purification, and identification of cardiac proteins S-thiolated during ischemia and reperfusion. J. Biol. Chem. 277 (2002) 9806-9811
102. Inagaki K., Begley R., Ikeno F., and Mochly-Rosen D. Cardioprotection by epsilon-protein kinase C activation from ischemia: continuous delivery and antiarrhythmic effect of an epsilon-protein kinase C-activating peptide. Circulation 111 (2005) 44-50
103. Hool L.C. Reactive oxygen species in cardiac signalling: from mitochondria to plasma membrane ion channels. Clin. Exp. Pharmacol. Physiol. 33 (2006) 146-151
104. Petrosillo G., Ruggiero F.M., DiVenosa N., and Paradies G. Decreased complex III activity in mitochondria isolated from rat heart subjected to ischemia and reperfusion: role of reactive oxygen species and cardiolipin. FASEB J. 17 (2003) U395-U413
105. Paradies G., Petrosillo G., Pistolese M., DiVenosa N., Federici A., and Ruggiero F.M. Decrease in mitochondrial complex I activity in ischemic/reperfused rat heart - involvement of reactive oxygen species and cardiolipin. Circ. Res. 94 (2004) 53-59
106. Echtay K.S., Esteves T.C., Pakay J.L., Jekabsons M.B., Lambert A.J., Portero Otin M., Pamplona R., Vidal Puig A.J., Wang S., Roebuck S.J., and Brand M.D. A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling. EMBO J. 22 (2003) 4103-4110
107. Chen C.-H., Budas G.R., Churchill E.N., Disatnik M.-H., Hurley T.D., and Mochly-Rosen D. Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science 321 (2008) 1493-1495
108. Schulz R., Kelm M., and Heusch G. Nitric oxide in myocardial ischemia/reperfusion injury. Cardiovasc. Res. 61 (2004) 402-413
109. Davidson S.M., and Duchen M.R. Effects of NO on mitochondrial function in cardiomyocytes: pathophysiological relevance. Cardiovasc. Res. 71 (2006) 10-21
110. Brown G.C., and Borutaite V. Nitric oxide and mitochondrial respiration in the heart. Cardiovasc. Res. 75 (2007) 283-290
111. Brookes P.S., Salinas E.P., DarleyUsmar K., Eiserich J.P., Freeman B.A., DarleyUsmar V.M., and Anderson P.G. Concentration-dependent effects of nitric oxide on mitochondrial permeability transition and cytochrome c release. J. Biol. Chem. 275 (2000) 20474-20479
112. Radi R., Cassina A., Hodara R., Quijano C., and Castro L. Peroxynitrite reactions and formation in mitochondria. Free Radic. Biol. Med. 33 (2002) 1451-1464
113. Brookes P.S., and DarleyUsmar V.M. Role of calcium and superoxide dismutase in sensitizing mitochondria to peroxynitrite-induced permeability transition. AmJ. Physiol. 286 (2004) H39-H46
114. Packer M.A., Scarlett J.L., Martin S.W., and Murphy M.P. Induction of the mitochondrial permeability transition by peroxynitrite. Biochem. Soc. Trans. 25 (1997) 909-914
115. Vieira H.L., Belzacq A.S., Haouzi D., Bernassola F., Cohen I., Jacotot E., Ferri K.F., El Hamel C., Bartle L.M., Melino G., Brenner C., Goldmacher V., and Kroemer G. The adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, and 4-hydroxynonenal. Oncogene 20 (2001) 4305-4316
116. Kerr P.M., Suleiman M.S., and Halestrap A.P. Reversal of permeability transition during recovery of hearts from ischemia and its enhancement by pyruvate. Am. J. Physiol. 276 (1999) H496-H502
117. Vandenberg J.I., Metcalfe J.C., and Grace A.A. Mechanisms of intracellular pH recovery following global ischaemia in the perfused heart. Circ. Res. 72 (1993) 993-1003
118. Vaughan-Jones R.D., and Spitzer K.W. Role of bicarbonate in the regulation of intracellular pH in the mammalian ventricular myocyte. Biochem. Cell. Biol. 80 (2002) 579-596
119. 2+ ions - a proposed model for phosphate-stimulated lipid peroxidation. J. Biol. Chem. 271 (1996) 2929-2934
120. Zorov D.B., Juhaszova M., and Sollott S.J. Mitochondrial ROS-induced ROS release: an update and review. Biochim. Biophys. Acta 1757 (2006) 509-517
121. Aon M.A., Cortassa S., Maack C., and O'Rourke B. Sequential opening of mitochondrial ion channels as a function of glutathione redox thiol status. J. Biol. Chem. 282 (2007) 21889-21900
122. Slodzinski M.K., Aon M.A., and O'Rourke B. Glutathione oxidation as a trigger of mitochondrial depolarization and oscillation in intact hearts. J. Mol. Cell. Cardiol. 45 (2008) 650-660
123. Aon M.A., Cortassa S., and O'Rourke B. Percolation and criticality in a mitochondrial network. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 4447-4452
124. + channel. Biochem. J. 246 (1987) 325-329
125. Ricci J.E., Gottlieb R.A., and Green D.R. Caspase-mediated loss of mitochondrial function and generation of reactive oxygen species during apoptosis. J. Cell. Biol. 160 (2003) 65-75
126. Ricci J.E., MunozPinedo C., Fitzgerald P., BaillyMaitre B., Perkins G.A., Yadava N., Scheffler I.E., Ellisman M.H., and Green D.R. Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain. Cell 117 (2004) 773-786
127. Halestrap A.P., Doran E., Gillespie J.P., and OToole A. Mitochondria and cell death. Biochem. Soc. Trans. 28 (2000) 170-177
128. Anversa P. Myocyte death in the pathological heart. Circ. Res. 86 (2000) 121-124
129. 2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. J. Clin. Invest. 117 (2007) 2431-2444
130. Garcia Dorado D., Rodniguez Sinovas A., Ruiz Meana M., Inserte J., Agullo L., and Cabestrero A. The end-effectors of preconditioning protection against myocardial cell death secondary to ischemia-reperfusion. Cardiovasc. Res. 70 (2006) 274-285
131. Duchen M.R., Mcguinness O., Brown L.A., and Crompton M. On the involvement of a cyclosporin-A sensitive mitochondrial pore in myocardial reperfusion injury. Cardiovasc. Res. 27 (1993) 1790-1794
132. Leyssens A., Crompton M., and Duchen M.R. A role of the mitochondrial permeability transition pore in cell injury by reactive oxygen species in isolated rat cardiomyocytes. J. Physiol. 494P (1996) P109-P110
133. Lemasters J.J., Nieminen A.L., Qian T., Trost L.C., and Herman B. The mitochondrial permeability transition in toxic, hypoxic and reperfusion injury. Mol. Cell. Biochem. 174 (1997) 159-165
134. 2+, pH, electrical potential, and membrane permeability in single living cells. Methods. Enzymol. 302 (1999) 341-358
135. Bernardi P., Scorrano L., Colonna R., Petronilli V., and DiLisa F. Mitochondria and cell death - mechanistic aspects and methodological issues. Eur. J. Biochem. 264 (1999) 687-701
136. Zorov D.B., Filburn C.R., Klotz L.O., Zweier J.L., and Sollott S.J. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J. Exp. Med. 192 (2000) 1001-1014
137. 2+ transients in rat ventricular myocytes. Circulation 105 (2002) 2666-2671
138. Akao M., O'Rourke B., Teshima Y., Seharaseyon J., and Marban E. Mechanistically distinct steps in the mitochondrial death pathway triggered by oxidative stress in cardiac myocytes. Circ. Res. 92 (2003) 186-194
139. Hausenloy D.J., Yellon D.M., Mani-Babu S., and Duchen M.R. Preconditioning protects by inhibiting the mitochondrial permeability transition. Am. J. Physiol. 287 (2004) H841-H849
140. 2+ overloading, trigger pH- and mitochondrial permeability transition-dependent death of adult rat myocytes after ischemia-reperfusion. Am. J. Physiol. 290 (2006) H2024-H2034
141. Khaliulin I., Clarke S.J., Lin H., Parker J., Suleiman M.-S., and Halestrap A.P. Temperature preconditioning of isolated rat hearts - a potent cardioprotective mechanism involving a reduction in oxidative stress and inhibition of the mitochondrial permeability transition pore. J. Physiol. 581 (2007) 1147-1161
142. Townsend P.A., Davidson S.M., Clarke S.J., Khaliulin I., Carroll C.J., Scarabelli T.M., Knight R.A., Stephanou A., Latchman D.S., and Halestrap A.P. Urocortin prevents mitochondrial permeability transition in response to reperfusion injury indirectly, by reducing oxidative stress. Am. J. Physiol. 293 (2007) H928-H938
143. Robin E., Guzy R.D., Loor G., Iwase H., Waypa G.B., Marks J.D., Hoek T.L., and Schumacker P.T. Oxidant stress during simulated ischemia primes cardiomyocytes for cell death during reperfusion. J. Biol. Chem. 282 (2007) 19133-19143
144. + and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J. Biol. Chem. 276 (2001) 2571-2575
145. Griffiths E.J., and Halestrap A.P. Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem. J. 307 (1995) 93-98
146. Halestrap A.P., Connern C.P., Griffiths E.J., and Kerr P.M. Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury. Mol. Cell. Biochem. 174 (1997) 167-172
147. Javadov S.A., Lim K.H.H., Kerr P.M., Suleiman M.S., Angelini G.D., and Halestrap A.P. Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition. Cardiovasc. Res. 45 (2000) 360-369
148. Javadov S., Huang C., Kirshenbaum L., and Karmazyn M. NHE-1 inhibition improves impaired mitochondrial permeability transition and respiratory function during postinfarction remodelling in the rat. J. Mol. Cell. Cardiol. 38 (2005) 135-143
149. Prendes M.G., Torresin E., Gonzalez M., Fernandez M.A., Perazzo J.C., Savino E.A., and Varela A. Protection of ischaemic-reperfused rat heart by dimethylamiloride is associated with inhibition of mitochondrial permeability transition. Clin. Exp. Pharmacol. Physiol. 35 (2008) 201-206
150. Javadov S., Choi A., Rajapurohitam V., Zeidan A., Basnakian A.G., and Karmazyn M. NHE-1 inhibition-induced cardioprotection against ischaemia/reperfusion is associated with attenuation of the mitochondrial permeability transition. Cardiovasc. Res. 77 (2008) 416-424
151. Ciminelli M., Ascah A., Bourduas K., and Burelle Y. Short term training attenuates opening of the mitochondrial permeability transition pore without affecting myocardial function following ischemia-reperfusion. Mol. Cell. Biochem. 291 (2006) 39-47
152. Nazareth W., Yafei N., and Crompton M. Inhibition of anoxia-induced injury in heart myocytes by cyclosporin-A. J. Mol. Cell. Cardiol. 23 (1991) 1351-1354
153. Griffiths E.J., and Halestrap A.P. Protection by cyclosporin A of ischemia reperfusion-induced damage in isolated rat hearts. J. Mol. Cell. Cardiol. 25 (1993) 1461-1469
154. Hausenloy D.J., Maddock H.L., Baxter G.F., and Yellon D.M. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?. Cardiovasc. Res. 55 (2002) 534-543
155. Hausenloy D.J., Duchen M.R., and Yellon D.M. Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury. Cardiovasc. Res. 60 (2003) 617-625
156. Argaud L., Gateau-Roesch O., Muntean D., Chalabreysse L., Loufouat J., Robert D., and Ovize M. Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury. J. Mol. Cell. Cardiol. 38 (2005) 367-374
157. Periasamy M. Calcineurin and the heartbeat, an evolving story. J. Mol. Cell. Cardiol. 34 (2002) 259-262
158. Schreiber S.L., and Crabtree G.R. The mechanism of action of cyclosporin-A and FK506. Immunol. Today 13 (1992) 136-142
159. Gomez L., Thibault H., Gharib A., Dumont J.M., Vuagniaux G., Scalfaro P., Derumeaux G., and Ovize M. Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice. Am. J. Physiol. Heart Circ. Physiol. 293 (2007) H1654-H1661
160. Shanmuganathan S., Hausenloy D.J., Duchen M.R., and Yellon D.M. Mitochondrial permeability transition pore as a target for cardioprotection in the human heart. Am. J. Physiol. 289 (2005) H237-H242
161. Piot C., Croisille P., Staat P., Thibault H., Rioufol G., Mewton N., Elbelghiti R., Cung T.T., Bonnefoy E., Angoulvant D., Macia C., Raczka F., Sportouch C., Gahide G., Finet G., Andre-Fouet X., Revel D., Kirkorian G., Monassier J.-P., Derumeaux G., and Ovize M. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N. Engl. J. Med. 359 (2008) 473-481
162. 2+-induced permeabilization of rat liver mitochondria. FEBS Lett. 279 (1991) 45-48
163. Sztark F., Ichas F., Ouhabi R., Dabadie P., and Mazat J.P. Effects of the anaesthetic propofol on the calcium-induced permeability transition of rat heart mitochondria: direct pore inhibition and shift of the gating potential. FEBS Lett. 368 (1995) 101-104
164. Lim K.H.H., Halestrap A.P., Angelini G.D., and Suleiman M.S. Propofol is cardioprotective in a clinically relevant model of normothermic blood cardioplegic arrest and cardiopulmonary bypass. Exp. Biol. Med. 230 (2005) 413-420
165. 2+ responses in intact hearts. Am. J. Physiol. 281 (2001) H1508-H1523
166. 2+ overload during ischemia in guinea pig intact hearts: reversal by 5-hydroxydecanoic acid. Anesth. Analg. 95 (2002) 1540-1546
167. Novalija E., Kevin L.G., Eells J.T., Henry M.M., and Stowe D.F. Anesthetic preconditioning improves adenosine triphosphate synthesis and reduces reactive oxygen species formation in mitochondria after ischemia by a redox dependent mechanism. Anesthesiology 98 (2003) 1155-1163
168. Chiari P.C., Bienengraeber M.W., Pagel P.S., Krolikowski J.G., Kersten J.R., and Warltier D.C. Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol-3-kinase signal transduction: evidence for anesthetic-induced postconditioning in rabbits. Anesthesiology 102 (2005) 102-109
169. Lange M., Roewer N., and Kehl F. Anesthetic preconditioning as the alternative to ischemic preconditioning. J. Thorac. Cardiovasc. Surg. 131 (2006) 252-253
170. Murphy M.P., and Smith R.A. Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu. Rev. Pharmacol. Toxicol. 47 (2007) 629-656
171. Adlam V.J., Harrison J.C., Porteous C.M., James A.M., Smith R.A.J., Murphy M.P., and Sammut I.A. Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J. 19 (2005) 1088-1095
172. Mentzer R.M., Lasley R.D., Jessel A., and Karmazyn M. Intracellular sodium hydrogen exchange inhibition and clinical myocardial protection. Ann. Thorac. Surg. 75 (2003) S700-S708
173. + exchanger during ischemia and reperfusion. Cardiovasc. Res. 57 (2003) 934-941
174. Mallet R.T., Sun J., Knott E.M., Sharma A.B., and Olivencia-Yurvati A.H. Metabolic cardioprotection by pyruvate: recent progress. Exp. Biol. Med. 230 (2005) 435-443
175. Peng C.F., Kane J.J., Straus K.D., and Murphy M.L. Improvement of mitochondrial energy production in ischaemic myocardium by in vivo infusion of ruthenium red. J. Cardiovasc. Pharmacol. 2 (1980) 45-54
176. Ferrari R., Raddino R., and Visioli O. The effects of ruthenium red on mitochondrial function during post-ischaemic reperfusion. J. Mol. Cell. Cardiol. 14 (1982) 737-740
177. Opie L. Myocardial stunning - a role for calcium antagonists during reperfusion. Cardiovasc. Res. 26 (1992) 20-24
178. Grover G.J., Dzwonczyk S., and Sleph P.G. Ruthenium red improves postischemic contractile function in isolated rat hearts. J. Cardiovasc. Pharmacol. 16 (1990) 783-789
179. Figueredo V.M., Dresdner Jr. K.P., Wolney A.C., and Keller A.M. Postischaemic reperfusion injury in the isolated rat heart: effect of ruthenium red. Cardiovasc. Res. 25 (1991) 337-342
180. Benzi R.H., and Lerch R. Dissociation between contractile function and oxidative metabolism in postischemic myocardium. Attenuation by ruthenium red administered during reperfusion. Circ. Res. 71 (1992) 567-576
181. Massoudy P., Becker B.F., Seligmann C., and Gerlach E. Preischaemic as well as postischaemic application of a calcium antagonist affords cardioprotection in the isolated guinea pig heart. Cardiovasc. Res. 29 (1995) 577-582
182. de J Garcia-Rivas G., Carvajal K., Correa F., and Zazueta C. Ru360, a specific mitochondrial calcium uptake inhibitor, improves cardiac post-ischaemic functional recovery in rats in vivo. Br. J. Pharmacol. 149 (2006) 829-837
183. Suleiman M.S. New concepts in the cardioprotective action of magnesium and taurine during the calcium paradox and ischaemia of the heart. Magnes. Res. 7 (1994) 295-312
184. Lareau S., Boyle A.J., Stewart L.C., Deslauriers R., Hendry P., Keon W.J., and Labow R.S. The role of magnesium in myocardial preservation. Magnes. Res. 8 (1995) 85-97
185. Maulik M., Maulik S.K., and Kumari R. Importance of timing of magnesium administration: a study on the isolated ischemic-reperfused rat heart. Magnes. Res. 12 (1999) 37-42
186. Argaud L., Gomez L., Gateau-Roesch O., Couture-Lepetit E., Loufouat J., Robert D., and Ovize M. Trimetazidine inhibits mitochondrial permeability transition pore opening and prevents lethal ischemia-reperfusion injury. J. Mol. Cell. Cardiol. 39 (2005) 893-899
187. Abozguia K., Clarke K., Lee L., and Frenneaux M. Modification of myocardial substrate use as a therapy for heart failure. Nat. Clin. Pract. Cardiovasc. Med. 3 (2006) 490-498
188. Schulz R., Cohen M.V., Behrends M., Downey J.M., and Heusch G. Signal transduction of ischemic preconditioning. Cardiovasc. Res. 52 (2001) 181-198
189. Yellon D.M., and Downey J.M. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol. Rev. 83 (2003) 1113-1151
190. Das D.K., and Maulik N. Cardiac genomic response following preconditioning stimulus. Cardiovasc. Res. 70 (2006) 254-263
191. VintenJohansen J., Yellon D.M., and Opie L.H. Postconditioning - a simple, clinically applicable procedure to improve revascularization in acute myocardial infarction. Circulation 112 (2005) 2085-2088
192. Yellon D.M., and Opie L.H. Postconditioning for protection of the infarcting heart. Lancet 367 (2006) 456-458
193. Thibault H., Piot C., and Ovize M. Postconditioning in man. Heart Fail Rev. 12 (2007) 245-248
194. Lim S.Y., Davidson S.M., Hausenloy D.J., and Yellon D.M. Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore. Cardiovasc. Res. 75 (2007) 530-535
195. 2+-induced mitochondrial permeability transition. Cardiovasc. Res. 61 (2004) 115-122
196. Clarke S.J., Khaliulin I., Das M., Parker J.E., Heesom K.J., and Halestrap A.P. Inhibition of mitochondrial permeability transition pore opening by ischemic preconditioning is probably mediated by reduction of oxidative stress rather than mitochondrial protein phosphorylation. Circ. Res. 102 (2008) 1082-1090
197. Khaliulin I., Schneider A., Houminer E., Borman J.B., and Schwalb H. Apomorphine prevents myocardial ischemia/reperfusion-induced oxidative stress in the rat heart. Free Radic. Biol. Med. 37 (2004) 969-976
198. Juhaszova M., Zorov D.B., Kim S.H., Pepe S., Fu Q., Fishbein K.W., Ziman B.D., Wang S., Ytrehus K., Antos C.L., Olson E.N., and Sollott S.J. Glycogen synthase kinase-3 beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J. Clin. Invest. 113 (2004) 1535-1549
199. Matsumoto-Ida M., Akao M., Takeda T., Kato M., and Kita T. Real-time 2-photon imaging of mitochondrial function in perfused rat hearts subjected to ischemia/reperfusion. Circulation 114 (2006) 1497-1503
200. Argaud L., GateauRoesch O., Raisky O., Loufouat J., Robert D., and Ovize M. Postconditioning inhibits mitochondrial permeability transition. Circulation 111 (2005) 194-197
201. Yamamura K., Steenbergen C., and Murphy E. Protein kinase C and preconditioning: role of the sarcoplasmic reticulum. Am. J. Physiol. 289 (2005) H2484-H2490
202. Osada M., Netticadan T., Tamura K., and Dhalla N.S. Modification of ischemia-reperfusion-induced changes in cardiac sarcoplasmic reticulum by preconditioning. Am. J. Physiol. 274 (1998) H2025-H2034
203. 2+ paradox-induced changes in heart. Am. J. Physiol. 278 (2000) H1008-H1115
204. Zucchi R., Ronca F., and Ronca-Testoni S. Modulation of sarcoplasmic reticulum function: a new strategy in cardioprotection?. Pharmacol. Ther. 89 (2001) 47-65
205. Hausenloy D.J., and Yellon D.M. Preconditioning and postconditioning: united at reperfusion. Pharmacol. Ther. 116 (2007) 173-191
206. Downey J.M., Davis A.M., and Cohen M.V. Signaling pathways in ischemic preconditioning. Heart Fail Rev. 12 (2007) 181-188
207. Murphy E., and Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol. Rev. 88 (2008) 581-609
208. Hanley P.J., and Daut J. K-ATP channels and preconditioning: a re-examination of the role of mitochondrial KATpchannels and an overview of alternative mechanisms. J. Mol. Cell. Cardiol. 39 (2005) 17-50
209. + movement through potassium channels in isolated rat heart and liver mitochondria. Biochim. Biophys. Acta 1777 (2008) 540-548
210. Gomez L., Paillard M., Thibault H., Derumeaux G., and Ovize M. Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion. Circulation 117 (2008) 2761-2768
211. Doran E., and Halestrap A.P. Cytochrome c release from isolated rat liver mitochondria can occur independently of outer-membrane rupture: possible role of contact sites. Biochem. J. 348 (2000) 343-350
212. Borutaite V., Budriunaite A., Morkuniene R., and Brown G.C. Release of mitochondrial cytochrome c and activation of cytosolic caspases induced by myocardial ischaemia. Biochim. Biophys. Acta 1537 (2001) 101-109
213. Cai J.Y., and Jones D.P. Superoxide in apoptosis - mitochondrial generation triggered by triggered by cytochrome c loss. J. Biol. Chem. 273 (1998) 11401-11404
214. Kennedy S.G., Kandel E.S., Cross T.K., and Hay N. Akt protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria. Mol. Cell. Biol. 19 (1999) 5800-5810
215. Datta S.R., Dudek H., Tao X., Masters S., Fu H.A., Gotoh Y., and Greenberg M.E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91 (1997) 231-241
216. Datta S.R., Katsov A., Hu L., Petros A., Fesik S.W., Yaffe M.B., and Greenberg M.E. 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol. Cell. 6 (2000) 41-51
217. Maurer U., Charvet C., Wagman A.S., Dejardin E., and Green D.R. Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol. Cell. 21 (2006) 749-760
218. Houser S.R., Piacentino III V., and Weisser J. Abnormalities of calcium cycling in the hypertrophied and failing heart. J. Mol. Cell. Cardiol. 32 (2000) 1595-1607
219. Ritter O., and Neyses L. The molecular basis of myocardial hypertrophy and heart failure. Trends Mol. Med. 9 (2003) 313-321
220. Heineke J., and Molkentin J.D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat. Rev. Mol. Cell. Biol. 7 (2006) 589-600
221. Wilkins B.J., and Molkentin J.D. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochem. Biophys. Res. Commun. 322 (2004) 1178-1191
222. 2+ in the heart: contraction versus intracellular signaling. J. Clin. Invest. 116 (2006) 623-626
223. Sayen M.R., Gustafsson A.B., Sussman M.A., Molkentin J.D., and Gottlieb R.A. Calcineurin transgenic mice have mitochondrial dysfunction and elevated superoxide production. Am. J. Physiol. 284 (2003) C562-C570
224. Millay D.P., Sargent M.A., Osinska H., Baines C.P., Barton E.R., Vuagniaux G., Sweeney H.L., Robbins J., and Molkentin J.D. Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy. Nat. Med. 14 (2008) 442-447
225. Merlini L., Angelin A., Tiepolo T., Braghetta P., Sabatelli P., Zamparelli A., Ferlini A., Maraldi N.M., Bonaldo P., and Bernardi P. Cyclosporin A corrects mitochondrial dysfunction and muscle apoptosis in patients with collagen VI myopathies. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 5225-5229
226. Ptak R.G., Gallay P.A., Jochmans D., Halestrap A.P., Ruegg U.T., Pallansch L.A., Bobardt M.D., de Bethune M.P., Neyts J., De Clercq E., Dumont J.M., Scalfaro P., Besseghir K., Wenger R.M., and Rosenwirth B. Inhibition of human immunodeficiency virus type 1 replication in human cells by debio-025, a novel cyclophilin binding agent. Antimicrob. Agents Chemother. 52 (2008) 1302-1317